Radical therapy of resectable and borderline resectable pancreatic cancer – present state of knowledge. Do we have sufficient data to use neoadjuvant treatment?
The incidence of pancreatic cancer has been increasing in recent years. It is expected to be the second or the third leading cause of cancer deaths in high-income countries in the next decade. Standard therapeutic management for patients with resectable pancreatic cancer is surgical resection follow...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2020-06-01
|
| Series: | Studia Medyczne |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Radical-therapy-of-resectable-and-borderline-resectable-pancreatic-cancer-present-state-of-knowledge-Do-we-have-sufficient-data-to-use-neoadjuvant-treatment-,67,41127,1,1.html |